XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Mar. 29, 2019
Mar. 30, 2018
Mar. 29, 2019
Mar. 30, 2018
Income Statement [Abstract]        
Revenue $ 3,999,987 $ 3,939,311 $ 8,265,336 $ 7,904,429
Costs and Expenses:        
Cost of services provided 3,639,959 3,563,009 7,434,404 7,085,239
Depreciation and amortization 147,908 152,864 298,629 286,713
Selling and general corporate expenses 88,285 88,444 192,415 180,612
Gain on sale of Healthcare Technologies 1,000 0 (156,309) 0
Costs and Expenses 3,877,152 3,804,317 7,769,139 7,552,564
Operating income 122,835 134,994 496,197 351,865
Interest and Other Financing Costs, net 84,178 92,653 167,155 166,786
Income Before Income Taxes 38,657 42,341 329,042 185,079
Provision for Income Taxes 9,347 14,625 49,054 (135,077)
Net income 29,310 27,716 279,988 320,156
Less: Net income (loss) attributable to noncontrolling interest (43) 147 (49) 303
Net income attributable to Aramark stockholders $ 29,353 $ 27,569 $ 280,037 $ 319,853
Earnings per share attributable to Aramark stockholders:        
Basic (in dollars per share) $ 0.12 $ 0.11 $ 1.14 $ 1.30
Diluted (in dollars per share) $ 0.12 $ 0.11 $ 1.11 $ 1.27
Weighted Average Shares Outstanding:        
Basic (in shares) 246,217 245,648 246,540 245,366
Diluted (in shares) 250,347 252,485 251,355 252,380